Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
102.6 USD | +0.54% |
|
-1.69% | -6.18% |
Jun. 27 | Barclays Trims Price Target on Revvity to $115 From $116 | MT |
Jun. 20 | Bionano Genomics Says Revvity to Commercialize VIA Software | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registration![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-6.18% | 12.59B | |
+0.91% | 204B | |
+3.74% | 178B | |
+28.89% | 156B | |
+31.66% | 113B | |
+1.18% | 64.26B | |
+19.45% | 54.98B | |
-3.44% | 47.44B | |
-9.28% | 36.7B | |
-0.10% | 34.84B |
- Stock Market
- Equities
- RVTY Stock
- News Revvity, Inc.
- Revvity Files Lawsuit Against Partner Cloud Software Group, Reaffirms 2024 Guidance